The United Bio-technology (hengqin) Co., Ltd.

This study is testing whether a new injectable medication called UBT251 can help people with overweight or obesity lose weight. About 205 participants will receive either the real injection or a placebo (a dummy shot with no medicine) for 24 weeks to see which is more effective a…

This study is testing a new injectable medication called UBT251 to see if it can help control blood sugar in people with type 2 diabetes. It will involve 211 adults and compare the new injection against a placebo and another standard diabetes drug over 24 weeks. The main goal is …